Clinical trials
Diabetic clinical trials
Below are recruiting diabetic clinical trials, each written for real people, not researchers. We’re tracking 2,208 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06739135Recruiting
Driving with diabetic neuropathy study
This study looks at how diabetic neuropathy (nerve damage from diabetes) affects driving safety. You may join if you have type 2 diabetes with or without neuropathy and are an experienced driver in the UK.
ManchesterAges 25–69 - NCT06748963Recruiting
Fasted exercise training for type 1 diabetes
This study tests if exercising before breakfast (while fasting) helps improve blood sugar control and heart health in people with type 1 diabetes. You'll continue using your insulin pump and glucose monitor, and attend supervised exercise sessions and MRI scans to measure changes in your body.
Edmonton, AlbertaAges 18–55 - NCT06751199Recruiting
Stem cells combined with islet transplant for diabetes
This trial tests if umbilical cord stem cells can improve the success of islet cell transplants for people with diabetes whose own pancreas no longer makes enough insulin. It aims to help patients achieve better blood sugar control and reduce dangerous low blood sugar episodes.
Shanghai, Shanghai MunicipalityAges 18–70 - NCT06752018Recruiting
Inflammation, heart disease, and diabetes study
This study looks at how inflammation affects heart disease and diabetes. It may help find new ways to prevent or treat these conditions.
AarhusAges 18 years+ - NCT06752928Recruiting
Comparing CGM to finger-stick glucose checks in hospitalized adults with type 1 diabetes
This study compares a continuous glucose monitor (CGM) to standard finger-stick blood sugar checks in adults with type 1 diabetes while they are in the hospital and after they go home. It aims to see if using a CGM leads to better blood sugar control during and after hospitalization.
Atlanta, GeorgiaAges 18 years+ - NCT06753994RecruitingPhase 1
Continuous ketone monitoring in type 1 diabetes with SGLT2 inhibitors
This study tests a new sensor that continuously measures ketone levels in people with type 1 diabetes who are also taking SGLT2 inhibitors. It aims to see if the sensor can help prevent diabetic ketoacidosis.
Montreal, QuebecAges 18 years+ - NCT06762314RecruitingPhase 2
Empagliflozin or semaglutide for overweight people with type 1 diabetes
This study tests two different medicines (empagliflozin or semaglutide) added to your usual insulin to see if they help with blood sugar control and weight loss in people with type 1 diabetes who are overweight or have obesity. It may be a good fit if your diabetes is not well controlled with insulin injections alone.
TantaAges 18–65 - NCT06767501Recruiting
Amnion graft for diabetic foot ulcers vs. standard care
This trial tests whether a special amnion membrane graft can help heal diabetic foot ulcers better than standard care alone. If you have a diabetic foot ulcer that hasn't healed after standard treatment, this study may offer a new option.
Roanoke, VirginiaAges 18 years+ - NCT06767774RecruitingPhase 4
Comparing two cholesterol treatments for heart patients
This study compares two different ways of lowering cholesterol: a moderate statin (pitavastatin) plus another drug (ezetimibe) versus a stronger statin alone. The goal is to see which approach is safer regarding the risk of developing new diabetes.
SeoulAges 18 years+ - NCT06770673Recruiting
Together Overcoming Diabetes - Great Plains
This study tests a program to help American Indian/Alaska Native adults with type 2 diabetes and a young family member (10-25 years old) work together to improve diabetes management. You and a youth in your home would join as a team and be assigned to one of two support programs.
Rapid City, South DakotaAges 10 years+ - NCT06770933RecruitingPhase 2
VX-01 pill for diabetic eye disease study
This trial tests if an oral medication called VX-01 can help people with diabetic eye disease (non-proliferative diabetic retinopathy) that is moderate to severe but not yet at the most advanced stage. It may be an option if you have type 1 or type 2 diabetes and have not had certain prior eye treatments.
Beverly Hills, CaliforniaAges 18 years+ - NCT06772168RecruitingPhase 3
New combo pill for diabetes and high cholesterol
This trial tests a new combination pill for people with type 2 diabetes and high cholesterol who are already on metformin. It aims to see if the new drug helps control both blood sugar and cholesterol better than current treatments.
AnyangAges 19–80 - NCT06774014Recruiting
Heart failure and diabetes: cell study
This study looks at how cells talk to each other in people who have both diabetes and heart failure. It may help doctors understand these conditions better.
Leeds, West YorkshireAges 18 years+ - NCT06782997Recruiting
Using a quick eye test to check for diabetes eye damage
This trial tests if a special eye exam (electroretinogram) done by a nurse can find early signs of diabetic retinopathy in people with diabetes who have no known eye problems yet. It aims to make screening easier and more accessible.
ReimsAges 18 years+ - NCT06787482RecruitingPhase 1/Phase 2
Peptide therapy for retinitis pigmentosa
This trial tests a new peptide therapy for people with retinitis pigmentosa (RP), a genetic eye disease that causes vision loss. The goal is to see if the treatment is safe and can help slow or improve vision loss.
CairoAges Any age - NCT06788743Recruiting
Sevoflurane vs. propofol for preventing confusion after surgery in older diabetics
This trial compares two common anesthesia drugs (sevoflurane gas vs. propofol injection) to see which one lowers the risk of confusion or delirium after surgery in older adults with diabetes. It aims to find a safer way to give anesthesia for your operation.
Xi’an, ShanxiAges 60 years+ - NCT06794658Recruiting
Using a smartphone app to help manage diabetes on insulin
This clinical trial tests whether using a smartphone app (called Caaring) can help people with diabetes on insulin better manage their blood sugar. If you take insulin and already monitor your blood sugar, this study may help you track your health remotely.
Valladolid, Castille and LeónAges Any age - NCT06798181Recruiting
Neuropathic pain and type 2 diabetes study
This study looks at nerve pain (called neuropathic pain) in people with type 2 diabetes. It aims to understand this type of pain better so doctors can help improve comfort and quality of life.
BilecikAges 18–100 - NCT06802861Recruiting
Aspirin metabolism in pregnant women at risk of pre-eclampsia
This study looks at how pregnant women at risk of pre-eclampsia process aspirin and how it affects their metabolism. Researchers will use blood and urine tests, along with body measurements and surveys, to learn more about how aspirin can help prevent pre-eclampsia.
Knoxville, TennesseeAges 18–45 - NCT06803446Recruiting
How does daily rhythm affect blood sugar during exercise in type 1 diabetes?
This study looks at how the time of day affects blood sugar control during moderate exercise and intense activity in teens with type 1 diabetes. It may help find the best times for exercise to manage glucose better.
Loos, NordAges 10–16 - NCT06803771Recruiting
Pancreatic health monitoring after diabetes diagnosis
This study follows people newly diagnosed with type 2 diabetes to check their pancreas health using blood tests and MRI scans. It aims to find any early signs of pancreatic disease.
Sandbach, CheshireAges 50–84 - NCT06810596Recruiting
Comparing two insulin infusion methods for diabetic ICU adults
This trial compares two ways of giving insulin through an IV to adults with diabetes in the intensive care unit to find which works better for controlling blood sugar.
IsmailiaAges 19 years+ - NCT06810635Recruiting
Polyphenol types in people with type 2 diabetes
This study looks at how different people process polyphenols (natural compounds in plant foods) based on their gut bacteria. It compares people with type 2 diabetes to those without diabetes to learn about possible health benefits.
Ghent, East FlandersAges 40–85 - NCT06810986Recruiting
Digital program for type 2 diabetes blood sugar control
This study tests a digital health program (app-based) to help people with type 2 diabetes better control their blood sugar. It may be a good option if you're already managing your diabetes with diet, pills, or certain medications and can use a smartphone.
Bandar Seri BegawanAges 18–70
Hear when a new Diabetic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for diabetic?
- Yes. Clin2 currently lists 2,208 recruiting diabetic studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a diabetic trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a diabetic trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.